Noxopharm Limited
Biotechnology-Research
Website
Company Tagline
Innovative Australian biotech developing novel treatments for cancer and inflammation, plus mRNA vaccine enhancements.
Industry Category
Business Keywords
Company Description
Noxopharm Limited is a pioneering Australian biotechnology company dedicated to discovering and developing innovative treatments for cancer and inflammation, alongside advancements in mRNA vaccines. With a commitment to improving global health, Noxopharm Limited focuses on creating novel therapeutic solutions.
Noxopharm Limited operates from its headquarters in Sydney - Castle Hill, New South Wales, at the address: Suite 71, 159 Ridgecrop Drive, Sydney - Castle Hill, New South Wales 2154, AU. The company leverages two innovative technology platforms, Sofra™ and Chroma™, to drive the active development of a growing pipeline of proprietary drugs, including its clinical drug candidate Veyonda®. These platforms underscore Noxopharm's dedication to cutting-edge research and development in the biotechnology sector.
Noxopharm Limited is also committed to making mRNA vaccines safer and more cost-effective. This dedication, combined with its focus on oncology and inflammatory diseases, positions Noxopharm Limited as a key player in the future of biopharmaceutical innovation. We invite the management of Noxopharm Limited to enhance your company's visibility and commercial opportunities by creating a customized and exclusive company showcase and product listing on our platform.
Noxopharm Limited est une entreprise biotechnologique australienne pionnière qui se consacre à la découverte et au développement de traitements innovants contre le cancer et l'inflammation, ainsi qu'aux progrès des vaccins à ARNm. Avec un engagement à améliorer la santé mondiale, Noxopharm Limited se concentre sur la création de solutions thérapeutiques novatrices.
Noxopharm Limited opère depuis son siège social à Sydney - Castle Hill, Nouvelle-Galles du Sud, à l'adresse suivante : Suite 71, 159 Ridgecrop Drive, Sydney - Castle Hill, Nouvelle-Galles du Sud 2154, AU. L'entreprise s'appuie sur deux plateformes technologiques innovantes, Sofra™ et Chroma™, pour stimuler le développement actif d'un pipeline croissant de médicaments exclusifs, y compris son médicament candidat clinique Veyonda®. Ces plateformes soulignent l'engagement de Noxopharm envers la recherche et le développement de pointe dans le secteur de la biotechnologie.
Noxopharm Limited s'engage également à rendre les vaccins à ARNm plus sûrs et plus rentables. Cet engagement, combiné à l'accent mis sur l'oncologie et les maladies inflammatoires, positionne Noxopharm Limited comme un acteur clé dans l'avenir de l'innovation biopharmaceutique. Nous invitons la direction de Noxopharm Limited à accroître la visibilité de votre entreprise et vos opportunités commerciales en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Noxopharm Limited with 3 companies in Biotechnology-Research
| Comparison Field |
Noxopharm LimitedMain Company |
PPDView Profile |
ARIAD Pharmaceutical...View Profile |
second scightView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 1991 | 2024 |
|
Company Size
|
— | 10,001+ | 201-500 | 1 employee |
|
City
|
Sydney - Castle Hill, New South Wales | Wilmington, NC | Cambridge, Massachusetts | |
|
Country
|
Australia | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
27 Total Skills
Biotechnology
Oncology
mRNA Vaccines
Pharmaceuticals
Drug Development
Inflammation Treatments
Biopharmaceutical Innovation
oncology
mRNA vaccines
pharmaceutical
nucleic acids
strategic partnerships
pancreatic cancer
psoriasis
preclinical research
oligonucleotides
SLE
mRNA therapeutics
autoimmune disease
small molecule
drug development
TLR8
TLR7
lupus
chronic inflammation
TBK1
biotechnology
|
16 Total
16 Unique
Unique Skills:
bioanalytical
biopharma
biopharmaceutical
biostatistics
clinical research
consulting
+10
|
2 Total
2 Unique
Unique Skills:
biotech
cancer
|
16 Total
16 Unique
Unique Skills:
bioinformatics
biostatistics
business intelligence
data analytics
data visualization
due diligence
+10
|
4
Total Companies1991
Oldest Founded2
Countries60
Unique SkillsSimilar Companies
Other organizations in the same industry
Moka Bio
Biotechnology-ResearchTransforming nature's wisdom into scientific validated products.
Algae+
Biotechnology-ResearchTransformamos CO₂ em Soluções Sustentáveis
NEXFID
Biotechnology-ResearchNous exploitons le pouvoir de l'insecte pour nourrir les animaux et les végétaux (Incubateur 2 Degré...
CEACAM Therapeutics
Biotechnology-ResearchRegenerative CEACAM biologics for joint health — veterinary-first, human-impact driven.
Alternative Company Names
This company is also known as